PubMed Health⌕ Search

PubMed · 10540726

[How does the immune system communicate with the brain?].

Abstract

It is now evident, that the immune system and the central nervous system (CNS) are functionally connected and interact with one another. The entrance of pathogenic micro-organisms or their products into the body evokes an array of systemic responses, i.e. acute-phase proteinemia, neutrophilic leucocytosis, changes in the circulating levels of various hormones, and fever with specific changes of behaviour. It is now generally recognised that many of these responses are modulated by the brain. Until 1995 it was thought that the transport of immune signals to the brain is mediated by a humoral mechanism, mainly by certain cytokines, produced by activated monocytes and macrophages. The mechanism for the transfer of cytokines through the blood-brain barrier was however not completely understood until recently. It was also not clear, how the fast febrile phase can be signalled within 15 min, if the sequence: external pyrogen-->monocytes-->cytokines-->prostaglandins-->stimulation of the hypothalamus-->fever, requires 40-60 minutes to be activated. In addition to the "classical" humoral mode of transfer, it has recently been proposed that the immune signals are transported to the brain by certain peripheral nerves, predominantly by the vagus. The macrophages of the liver (Kupfer cells) start producing small amounts of cytokines in response to their activation by bacterial lipopolisaccharides, coupled into a complex with the already pre-activated anaphylatoxic component of the complement. These cytokines can immediately activate adjacent sensory paraganglia of the hepatic vagus nerve, which carries these stimuli to the nucleus tractus solitarius, which in turn sends them out to the hypothalamus via the ascending noradrenergic pathways. This fast avenue of communication between the immune system and the brain is activated not only in pathological situations, corresponding to fever, but is an important component of systemic homeostasis, e.g. regulation of body temperature.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Z Mariak. [How does the immune system communicate with the brain?].. https://pubmed.ncbi.nlm.nih.gov/10540726/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A MAGIBU-based model for pediatric and juvenile CNS tumors: an in-house epigenetic decision-support framework compared with online DNA methylation classifiers.

Background: DNA methylation profiling is a tool that provides key support for central nervous system (CNS) tumor classification. However, diagnostically ambiguous pediatric cases may result in discordant outputs across classifiers. We developed MAGIBU, a cross-platform, projection-based framework that embeds individual methylomes into a fixed CNS reference landscape, ranking diagnostic entities by local epigenetic proximity to support clinician-led integrative diagnosis. Methods: As a proof-of-concept, we evaluated MAGIBU in eight morphologically challenging pediatric/juvenile CNS tumors with unresolved diagnoses after institutional and central pathology review. To establish a benchmark in the absence of a definitive histopathological ground truth, a consensus epigenetic reference was defined a priori for cases showing concordant results between the Heidelberg CNS Tumor Methylation Classifier and Methylscape Analysis. Comparisons were also performed with Epigenomic Digital Pathology (EpiDiP). To validate MAGIBU beyond this discovery cohort, performance was assessed at the family level across the CNS methylation spectrum (n = 678, 28 methylation families), on non-array platforms (whole-genome bisulfite sequencing and Oxford Nanopore), and in a focused analysis of the low-grade glioma and diffuse midline glioma compartment across four independent cohorts (n = 670). Results: In the discovery cohort, MAGIBU achieved high concordance with the consensus reference (Cohen's κ = 0.855), outperforming EpiDiP (κ = 0.278), which frequently placed low-grade tumors in proximity to higher-grade reference regions. Conclusions: MAGIBU provides a stable, quantitative differential diagnosis framework that mitigates the limitations of rigid categorical assignments. By leveraging a distance-based proximity metric, it offers a transparent decision-support tool that integrates effectively with clinical, radiological, and molecular data. While performance is inherently dependent on reference atlas composition, MAGIBU represents a robust complementary approach for the diagnostic workup of ambiguous CNS tumors.

Brain↗

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans.

Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders, including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of micro- and macrocephaly in deletion and duplication carriers, respectively. The underlying brain structural diversity remains largely unknown. We systematically called CNVs in 38 cohorts from the large-scale ENIGMA-CNV collaboration and the UK Biobank and identified 28 1q21.1 distal deletion and 22 duplication carriers and 37,088 non-carriers (48% male) derived from 15 distinct magnetic resonance imaging scanner sites. With standardized methods, we compared subcortical and cortical brain measures (all) and cognitive performance (UK Biobank only) between carrier groups also testing for mediation of brain structure on cognition. We identified positive dosage effects of copy number on intracranial volume (ICV) and total cortical surface area, with the largest effects in frontal and cingulate cortices, and negative dosage effects on caudate and hippocampal volumes. The carriers displayed distinct cognitive deficit profiles in cognitive tasks from the UK Biobank with intermediate decreases in duplication carriers and somewhat larger in deletion carriers-the latter potentially mediated by ICV or cortical surface area. These results shed light on pathobiological mechanisms of neurodevelopmental disorders, by demonstrating gene dose effect on specific brain structures and effect on cognitive function.

Brain↗